Algae found to inhibit SARS-CoV-2 infection in vitro
A recent study posted to Research Square* preprint server demonstrated that dry algal powders inhibit severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in vitro. Study: In Vitro...
Cell
-
-
SARS-CoV-2 emerging variants display enhanced syncytia formation
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first detected during an outbreak in late 2019 in Wuhan, China. Since the emergence of this virus,...
-
Xanthohumol as a potent pan-inhibitor for various coronaviruses
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus infecting humans and livestock worldwide. Not all coronavirus infections cause major symptoms but some...
-
Kidney cancer study provides new insights into tumor invasion and metastatic competence
How cancers metastasize remains poorly understood. The process begins when cancer cells break off from a tumor and invade blood and lymphatic vessels, the body’s...
-
Genetic marker linked to higher risk of death in COVID-19 patients
With more than 360 million cases worldwide and over 5.59 million deaths that have been caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...
-
-360x180.jpg)
Scientists develop an extremely potent siRNA with broad activity against SARS-CoVs
Researchers in Germany have developed a promising approach to suppressing the viral replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that...
-
Biomarker predicts severity of SARS-CoV-2 infection in patients
The coronavirus disease 2019 (COVID-19) presents with different levels of severity. A new study published on the preprint server medRxiv* investigates a biomarker to predict...
-
SARS-CoV-2 Omicron variant uses endosomal entry pathway and grows in upper respiratory tract cells
In a recent article published on the bioRxiv* preprint server, researchers demonstrate that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant grows rapidly...
-
bit.bio appoints Kathryn Corzo as Chief Operating Officer
Cell coding company bit.bio today announces the key appointment of Kathryn Corzo as Chief Operating Officer. She started in the role on 1 November 2021....
-
Study highlights the usefulness of organoids for basic research into coronaviruses
Researchers from the group of Hans Clevers in collaboration with the group of Bart Haagmans (Erasmus MC) established an organoid biobank to search for the...
-
Discovery of new protein could lead to effective treatments for developmental, neurological disorders
Understanding how the brain develops is crucial to formulating treatments and management protocols for a variety of developmental disorders, as well as degenerative neurological diseases....
-
Drug used to treat lung cancer could help improve survival rates for bladder cancer patients
Scientists from the University of Sheffield have discovered a drug already used to treat lung cancer could help to improve survival rates for bladder cancer...